These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Premature cardiovascular disease in young women with heterozygous familial hypercholesterolemia. van der Graaf A; Hutten BA; Kastelein JJ; Vissers MN Expert Rev Cardiovasc Ther; 2006 May; 4(3):345-51. PubMed ID: 16716095 [TBL] [Abstract][Full Text] [Related]
8. [Management in familial hypercholesterolaemia in children and adolescents. Position of the Lipid Expert Forum]. Myśliwiec M; Walczak M; Małecka-Tendera E; Dobrzańska A; Cybulska B; Filipiak KJ; Mazur A; Jarosz-Chobot P; Szadkowska A; Rynkiewicz A; Chybicka A; Socha P; Brandt A; Kubalska J; Bautembach-Minkowska J; Limon J; Zdrojewski T; Limon J; Banach M; Kardiol Pol; 2013; 71(10):1099-105. PubMed ID: 24197602 [No Abstract] [Full Text] [Related]
9. Familial hypercholesterolemia: current treatment and advances in management. Huijgen R; Vissers MN; Defesche JC; Lansberg PJ; Kastelein JJ; Hutten BA Expert Rev Cardiovasc Ther; 2008 Apr; 6(4):567-81. PubMed ID: 18402545 [TBL] [Abstract][Full Text] [Related]
10. Familial hypercholesterolaemia: different perspectives. Jones JL; Lakasing E; Archontakis S Nurs Stand; 2009 Aug 19-25; 23(50):35-8. PubMed ID: 19736707 [TBL] [Abstract][Full Text] [Related]
11. Heterozygous familial hypercholesterolemia case study. Friedrich DA J Am Acad Nurse Pract; 2010 Oct; 22(10):523-6. PubMed ID: 21040085 [TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia. Katsiki N; Athyros VG; Karagiannis A; Mikhailidis DP Int Angiol; 2011 Jun; 30(3):295; author reply 296. PubMed ID: 21617615 [No Abstract] [Full Text] [Related]
13. Familial hypercholesterolemia: a decade of progress. Gidding SS J Pediatr; 2010 Feb; 156(2):176-7. PubMed ID: 20105635 [No Abstract] [Full Text] [Related]
15. [A patient with the homozygote form of familial hypercholesterolemia]. Gorter JW; Schilte PP; Lansberg PJ; Kastelein JJ; Bakker HD Tijdschr Kindergeneeskd; 1991 Jun; 59(3):88-91. PubMed ID: 1862513 [TBL] [Abstract][Full Text] [Related]
16. After the failure of ENHANCEd cholesterol lowering in familial hypercholesterolemia, SEAS of problems with ezetimibe. Mascitelli L; Ravnskov U; Pezzetta F; Goldstein MR Angiology; 2009; 60(1):127-8; author reply 129-30. PubMed ID: 19049996 [No Abstract] [Full Text] [Related]
17. Guidelines for the identification and management of patients with familial hypercholesterolaemia (FH): are we coming to a consensus? Humphries SE Atheroscler Suppl; 2011 Oct; 12(2):217-20. PubMed ID: 22230092 [No Abstract] [Full Text] [Related]
18. A keen eye for risk. Ford TJ; Rocchiccioli P BMJ; 2018 Feb; 360():j5884. PubMed ID: 29419393 [No Abstract] [Full Text] [Related]
19. Dietary and drug treatment of severe hypercholesterolaemia. Lewis B Beitr Infusionsther; 1988; 23():39-46. PubMed ID: 2484781 [No Abstract] [Full Text] [Related]
20. [Is detection and treatment of familial hypercholesterolemia indicated in children?]. Bakker HD; Wiegman A; Defesche JC; Kastelein JJ Ned Tijdschr Geneeskd; 1997 Dec; 141(52):2548-51. PubMed ID: 9555154 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]